Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease

NCT00338117 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
554
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators